N. Isham

3.2k total citations · 2 hit papers
37 papers, 2.1k citations indexed

About

N. Isham is a scholar working on Epidemiology, Cell Biology and Infectious Diseases. According to data from OpenAlex, N. Isham has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 16 papers in Cell Biology and 14 papers in Infectious Diseases. Recurrent topics in N. Isham's work include Fungal Infections and Studies (21 papers), Nail Diseases and Treatments (20 papers) and Plant Pathogens and Fungal Diseases (16 papers). N. Isham is often cited by papers focused on Fungal Infections and Studies (21 papers), Nail Diseases and Treatments (20 papers) and Plant Pathogens and Fungal Diseases (16 papers). N. Isham collaborates with scholars based in United States, Switzerland and India. N. Isham's co-authors include Mahmoud A. Ghannoum, Iman Salem, Pranab K. Mukherjee, Steven D. Leidich, Katyna Borroto–Esoda, Neil S. Ryder, Mahmoud Ghannoum, Ingrid Leitner, Emily L. Larkin and Christopher Hager and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.

In The Last Decade

N. Isham

37 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Gut Microbiome as a Major Regulator of the Gut-Skin Axis

2018 435 citations Iman Salem, N. Isham et al. Frontiers in Microbiology profile →
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation

2017 316 citations Emily L. Larkin, Christopher Hager et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Isham United States	23	1.3k	779	551	373	364	37	2.1k
Tahereh Shokohi Iran	25	1.1k 0.9×	961 1.2×	535 1.0×	102 0.3×	141 0.4×	148	1.9k
Keisha Findley United States	10	519 0.4×	289 0.4×	257 0.5×	429 1.2×	500 1.4×	11	1.4k
Pietro Nenoff Germany	31	3.2k 2.5×	615 0.8×	2.2k 4.0×	447 1.2×	184 0.5×	230	3.8k
Oliverio Welsh Mexico	28	1.4k 1.1×	676 0.9×	279 0.5×	117 0.3×	140 0.4×	81	2.4k
Ali Rezaei‐Matehkolaei Iran	27	2.1k 1.6×	738 0.9×	1.5k 2.8×	75 0.2×	132 0.4×	95	2.5k
Mahdi Abastabar Iran	24	1.1k 0.9×	864 1.1×	691 1.3×	33 0.1×	223 0.6×	133	1.9k
Nalu T. A. Peres Brazil	16	688 0.5×	256 0.3×	369 0.7×	47 0.1×	194 0.5×	39	1.1k
Parivash Kordbacheh Iran	20	641 0.5×	525 0.7×	331 0.6×	56 0.2×	128 0.4×	94	1.2k
M G Rinaldi United States	22	1.4k 1.1×	1.7k 2.1×	363 0.7×	20 0.1×	268 0.7×	29	2.3k
J.I. Ross United Kingdom	15	341 0.3×	610 0.8×	67 0.1×	596 1.6×	382 1.0×	16	1.5k

Countries citing papers authored by N. Isham

Since Specialization

Citations

This map shows the geographic impact of N. Isham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Isham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Isham more than expected).

Fields of papers citing papers by N. Isham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Isham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Isham. The network helps show where N. Isham may publish in the future.

Co-authorship network of co-authors of N. Isham

This figure shows the co-authorship network connecting the top 25 collaborators of N. Isham. A scholar is included among the top collaborators of N. Isham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Isham. N. Isham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghannoum, Mahmoud A., et al.. (2020). Efficacy of Ibrexafungerp (SCY-078) against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model. Antimicrobial Agents and Chemotherapy. 64(10). 31 indexed citations

Hager, Christopher, N. Isham, Jyotsna Chandra, et al.. (2019). Effects of a Novel Probiotic Combination on Pathogenic Bacterial-Fungal Polymicrobial Biofilms. mBio. 10(2). 62 indexed citations

Ghannoum, Mahmoud A., L. Long, N. Isham, et al.. (2019). Activity of a Novel 1,3-Beta- d -Glucan Synthase Inhibitor, Ibrexafungerp (Formerly SCY-078), against Candida glabrata. Antimicrobial Agents and Chemotherapy. 63(12). 24 indexed citations

Chandra, J., L. Long, N. Isham, et al.. (2018). In Vitro and In Vivo Activity of a Novel Catheter Lock Solution against Bacterial and Fungal Biofilms. Antimicrobial Agents and Chemotherapy. 62(8). 20 indexed citations

Salem, Iman, et al.. (2018). The Gut Microbiome as a Major Regulator of the Gut-Skin Axis. Frontiers in Microbiology. 9. 1459–1459. 435 indexed citations breakdown →

Larkin, Emily L., Christopher Hager, Jyotsna Chandra, et al.. (2017). The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Antimicrobial Agents and Chemotherapy. 61(5). 316 indexed citations breakdown →

Ghannoum, Mahmoud, et al.. (2017). Examining the importance of laboratory and diagnostic testing when treating and diagnosing onychomycosis. International Journal of Dermatology. 57(2). 131–138. 41 indexed citations

Ghannoum, Mahmoud A. & N. Isham. (2014). Fungal Nail Infections (Onychomycosis): A Never-Ending Story?. PLoS Pathogens. 10(6). e1004105–e1004105. 96 indexed citations

Shiboski, Caroline H., Huichao Chen, Mahmoud A. Ghannoum, et al.. (2014). Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253. The International Journal of Tuberculosis and Lung Disease. 18(6). 682–688. 9 indexed citations

10.

Ghannoum, Mahmoud A., N. Isham, & Vincenzo Catalano. (2013). A second look at efficacy criteria for onychomycosis: clinical and mycological cure. British Journal of Dermatology. 170(1). 182–187. 28 indexed citations

11.

Ghannoum, Mahmoud A., N. Isham, & Lisa Long. (2012). Optimization of an Infected Shoe Model for the Evaluation of an Ultraviolet Shoe Sanitizer Device. Journal of the American Podiatric Medical Association. 102(4). 309–313. 26 indexed citations

12.

Ghannoum, Mahmoud A., et al.. (2011). Activity of TDT 067 (Terbinafine in Transfersome) against Agents of Onychomycosis, as Determined by Minimum Inhibitory and Fungicidal Concentrations. Journal of Clinical Microbiology. 49(5). 1716–1720. 51 indexed citations

13.

Ghannoum, Mahmoud A., et al.. (2010). Repeated exposure of Candida spp. to miconazole demonstrates no development of resistance. Mycoses. 54(4). e175–e177. 10 indexed citations

14.

Ghannoum, Mahmoud A., et al.. (2009). Comparison of thein vitroactivity of terbinafine and lanoconazole against dermatophytes. Mycoses. 53(4). 311–3. 10 indexed citations

15.

Isham, N. & Mahmoud A. Ghannoum. (2009). Antifungal activity of miconazole against recent Candida strains. Mycoses. 53(5). 434–437. 43 indexed citations

16.

Ghannoum, Mahmoud A., et al.. (2008). Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial. British Journal of Dermatology. 159(3). 711–713. 26 indexed citations

17.

Ghannoum, Mahmoud, N. Isham, & Daniel F. Sheehan. (2006). Voriconazole Susceptibilities of Dermatophyte Isolates Obtained from a Worldwide Tinea Capitis Clinical Trial. Journal of Clinical Microbiology. 44(7). 2579–2580. 32 indexed citations

18.

Burkhart, Craig G., Craig N. Burkhart, & N. Isham. (2005). Synergistic antimicrobial activity by combining an allylamine with benzoyl peroxide with expanded coverage against yeast and bacterial species. British Journal of Dermatology. 154(2). 341–344. 16 indexed citations

19.

Ghannoum, Mahmoud A., N. Isham, Rana Hajjeh, et al.. (2003). Tinea capitis in Cleveland: Survey of elementary school students. Journal of the American Academy of Dermatology. 48(2). 189–193. 81 indexed citations

20.

Mukherjee, Pranab K., Steven D. Leidich, N. Isham, et al.. (2002). Clinical Trichophyton rubrum Strain Exhibiting Primary Resistance to Terbinafine. Antimicrobial Agents and Chemotherapy. 47(1). 82–86. 238 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact